Rising healthcare costs and flaws in the Medicare Advantage program are likely to dominate healthcare reform discussions in 2026, according to one PitchBook analyst. Potential policy changes could focus on improving affordability in the ACA market and fixing distorted incentives in Medicare Advantage. The post Rising Costs & Medicare Advantage Flaws to Drive Healthcare Reform…
This brief examines Medicaid’s pregnancy and postpartum coverage and its support for strengthening and improving maternal health outcomes.
It is our obligation to do our part to find ways to improve patient outcomes and lower health care costs. This often means continuously finding better, more efficient ways to solve problems, utilizing the most optimal tools and data we have at our disposal. And as of right now, and for the foreseeable future, that…
Bessemer Venture Partners predicted that 2026 will be a breakout year for healthcare AI, driven by increased adoption of clinical AI, a new class of AI-first value-based care companies, and the emerging digital health category of data infrastructure tools. The post How Bessemer Sees 2026 Shaping Up as Healthcare AI’s Breakout Year appeared first on…
Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn. The post Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence appeared first on MedCity News.
Patient engagement still has a long way to go, and hinges on patient access. According to the 2024 Experian State of Patient Access survey, just 28% of patients feel access has improved since the previous years. However, more than half (51%) feel it has remained static. Today’s patients are tech-savvy and have access to more…
Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing. But the Department of Health and Human Services has canceled a $590 million contract to support Moderna’s pivotal trial. The post Bird Flu Threat Still…
Amid sweeping cuts to federal government health agencies by the Trump Administration, much of the public opposes cuts to funding and staffing, including some Republicans. Support of many of these cuts is largely partisan, however, there is agreement across parties when it comes to opposing cuts to Social Security, Medicare, and Medicaid.
Highmark Health recently announced a partnership with AI technology company Abridge to deploy its ambient clinical documentation platform across Allegheny Health Network and co-develop a new prior authorization solution. The post Highmark Health, Abridge Partner to Scale AI for Payers/Providers appeared first on MedCity News.
Omeros’s complement system drug Yartemlea is now FDA approved for treating a severe and potentially fatal complication of hematopoietic stem cell transplants. Our recap of other regulatory actions includes drug approvals in cancer, rare disease, and metabolic disorders. The post Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy appeared first on MedCity…